293
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Conventional blood tests in predicting influenza A (H1N1) rapidly

, , &
Pages 197-203 | Received 21 Apr 2011, Accepted 10 Oct 2011, Published online: 07 Dec 2011

References

  • Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708–19.
  • World Health Organization. WHO information for laboratory diagnosis of pandemic (H1N1) 2009 virus in humans – revised. [cited June 15, 2010]; Available from: http://www.who.int/csr/resources/publications/swineflu/realtimeptpcr/en/
  • Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis 2009;49:1090–3.
  • Korea Centers for Disease Control and Prevention. Pandemic H1N1 2009 Monitoring patterns and levels of domestic activity. Seoul Korea: Korea Centers for Disease Control and Prevention. [cited June 15, 2010]; Available from: http://www.cdc.go.kr
  • Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361:2507–17.
  • Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009. Wkly Epidemiol Rec 2009;84:237–44.
  • Chan YL, Tseng CP, Tsay PK, Chang SS, Chiu TF, Chen JC. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004;8:R12–20.
  • Piacentini E, Sanchez B, Arauzo V, Calbo E, Cuchi E, Nava JM. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study. J Crit Care 2011;26:201–5.
  • Ciccozzi M, Babakir-Mina M, Lo Presti A, Marcuccilli F, Perno CF, Ciotti M. Phylogenesis and clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. Open Virol J 2011;5:22–6.
  • Crowe S, Utley M, Walker G, Grove P, Pagel C. A model to evaluate mass vaccination against pneumococcus as a countermeasure against pandemic influenza. Vaccine 2011;29: 5065–77.
  • Juven T, Mertsola J, Toikka P, Virkki R, Leinonen M, Ruuskanen O. Clinical profile of serologically diagnosed pneumococcal pneumonia. Pediatr Infect Dis J 2001;20:1028–33.
  • Poeppl W, Hell M, Herkner H, Stoiser B, Fritsche G, Schurz-Bamieh N, Poeppl G, Gattringer R, Jones N, Maass M, Egle A, Burgmann H. Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria. Infection 2011; 39:341–52.
  • Okimoto N, Hayashi Y, Ishiga M, Nanba F, Kishimoto M, Yagi S, Kurihara T, Asaoka N, Tamada S. Procalcitonin and severity of community-acquired pneumonia. J Infect Chemother 2009;15:426–7.
  • Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, Teixeira PJ. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006;10:R125.
  • Chang HL, Chen KT, Lai SK, Kuo HW, Su IJ, Lin RS, Sung FC. Hematological and biochemical factors predicting SARS fatality in Taiwan. J Formos Med Assoc 2006;105:439–50.
  • Wong RS, Wu A, To KF, Lee N, Lam CW, Wong CK, Chan PK, Ng MH, Yu LM, Hui DS, Tam JS, Cheng G, Sung JJ. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326: 1358–62.
  • Sheth AN, Patel P, Peters PJ. Influenza and HIV: lessons from the 2009 H1N1 Influenza Pandemic. Curr HIV/AIDS Rep 2011;8:181–91.
  • Quist J, Hill AR. Serum lactate dehydrogenase (LDH) in Pneumocystis carinii pneumonia, tuberculosis, and bacterial pneumonia. Chest 1995;108:415–8.
  • Portilla J, Sanchez Paya J, Boix V, Munoz C, Tamarit J, Merino J, Perez-Mateo M. [The usefulness of different markers in the diagnosis of advanced HIV infection]. Med Clin (Barc) 1994;103:725–9.
  • Miyazaki T, Honda A, Ikegami T, Hara T, Saitoh Y, Hirayama T, Doy M, Matsuzaki Y. The associated markers and their limitations for the primary screening of HCV carriers in public health examination. Hepatol Res 2009; 39:664–74.
  • Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58: 521–4.
  • Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945–52.
  • Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021–5.
  • Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708–19.
  • Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April–June 2009. Euro Surveill 2009;14.
  • Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605–15.
  • Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009;84:185–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.